Potent bace-1 inhibitor design using pharmacophore modeling, in silico screening and molecular docking studies
2011

Designing Effective BACE-1 Inhibitors

Sample size: 20 publication Evidence: high

Author Information

Author(s): John Shalini, Thangapandian Sundarapandian, Sakkiah Sugunadevi, Lee Keun Woo

Primary Institution: Gyeongsang National University

Hypothesis

Can a pharmacophore model accurately identify potential BACE-1 inhibitors?

Conclusion

The best pharmacophore hypothesis, Hypo 1, effectively identifies two compounds as potential leads for BACE-1 inhibition.

Supporting Evidence

  • Hypo 1 was validated with a high correlation coefficient of 0.977.
  • The pharmacophore model identified 773 compounds with estimated activity values less than 100 nM.
  • Molecular docking studies confirmed the binding interactions of the identified compounds with BACE-1.

Takeaway

Scientists created a model to find new drugs that can stop a brain enzyme linked to Alzheimer's disease, and they found two promising candidates.

Methodology

A ligand-based computational approach was used to generate pharmacophore hypotheses and validate them through various methods including database screening and molecular docking.

Potential Biases

Potential bias in the selection of training and test compounds could affect the model's predictive accuracy.

Limitations

The study relies on computational predictions which may not fully capture biological complexities.

Statistical Information

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1471-2105-12-S1-S28

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication